One Dose, One Cure: MSF's perspective on a new cure for sleeping sickness

One Dose, One Cure: MSF's perspective on a new cure for sleeping sickness

In 2014, Javid Abdelmoneim, MSF International President, traveled to a remote corner of the Democratic Republic of Congo to visit an MSF sleeping sickness programme. What he witnessed there mirrored what MSF doctors saw over 20 years ago when they called to create DNDi – medical neglect. 🛖 Back then, a positive sleeping sickness diagnosis meant being removed from your community for weeks to receive treatment far from home. A treatment so toxic it killed 1 in 20 patients. 💊 Today, acoziborole cures sleeping sickness with a one-day treatment course of three pills and is effective for even the most severe cases. 🙏 Acoziborole represents everything MSF and our other founding partners imagined when they created DNDi in 2003: innovation driven by need, and science designed with the most neglected communities in mind. 📽️ Over the next weeks, we will be sharing stories of some of those who played a role in making medical history, and what this milestone means. Follow us to hear their voices! #1Dose1Cure #GlobalHealth #NeglectedDiseases #beatNTDs #SleepingSickness ------- The Drugs for Neglected Diseases initiative (DNDi) is an international non-profit developing safe, effective, and affordable treatments for the most neglected patients. https://dndi.org